⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IMVT News
Immunovant, Inc. Common Stock
Form 8-K
sec.gov
IMVT
ROIV
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended September 30, 2026
globenewswire.com
IMVT
ROIV
Immunovant to Report Financial Results for the Second Fiscal Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026
globenewswire.com
ROIV
IMVT
Kuehn Law Encourages Investors of Immunovant, Inc. to Contact Law Firm
prnewswire.com
IMVT
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Immunovant, Inc. (IMVT) And Encourages Shareholders to Reach Out
accessnewswire.com
IMVT
IMVT Investors with $100,000 in Losses Have Opportunity to Join Immunovant, Inc. Fraud Investigation with SBS Law
businesswire.com
IMVT
Bronstein, Gewirtz & Grossman, LLC Initiate an Investigation into Allegations Against Immunovant, Inc. (IMVT) And Encourages Shareholders to Reach Out
accessnewswire.com
IMVT
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Immunovant, Inc. (IMVT) and Encourages Shareholders to Learn More About the Investigation
accessnewswire.com
IMVT
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Immunovant, Inc. (IMVT) and Encourages Investors to Learn More About the Investigation
accessnewswire.com
IMVT
Immunovant, Inc. (IMVT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation
accessnewswire.com
IMVT